Susquehanna International Group’s Cascadian Therapeutics, Inc. CASC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q1 | – | Sell |
-57,192
| Closed | -$212K | – | 5201 |
|
|
2017
Q4 | $212K | Buy |
57,192
+40,080
| +234% | +$149K | ﹤0.01% | 3091 |
|
|
2017
Q3 | $70K | Buy |
+17,112
| New | +$70K | ﹤0.01% | 2931 |
|
|
2017
Q2 | – | Sell |
-225,621
| Closed | -$934K | – | 4893 |
|
|
2017
Q1 | $934K | Buy |
225,621
+177,849
| +372% | +$736K | ﹤0.01% | 1742 |
|
|
2016
Q4 | $206K | Buy |
47,772
+5,974
| +14% | +$25.8K | ﹤0.01% | 3699 |
|
|
2016
Q3 | $411K | Buy |
+41,798
| New | +$411K | ﹤0.01% | 2110 |
|
|
2016
Q2 | – | Sell |
-36,946
| Closed | -$282K | – | 4594 |
|
|
2016
Q1 | $282K | Buy |
36,946
+4,350
| +13% | +$33.2K | ﹤0.01% | 3068 |
|
|
2015
Q4 | $434K | Buy |
32,596
+19,623
| +151% | +$261K | ﹤0.01% | 3106 |
|
|
2015
Q3 | $213K | Sell |
12,973
-2,158
| -14% | -$35.4K | ﹤0.01% | 3738 |
|
|
2015
Q2 | $340K | Buy |
+15,131
| New | +$340K | ﹤0.01% | 3676 |
|
|
2015
Q1 | – | Sell |
-3,435
| Closed | -$39K | – | 4754 |
|
|
2014
Q4 | $39K | Buy |
+3,435
| New | +$39K | ﹤0.01% | 4289 |
|
|
2014
Q3 | – | Sell |
-25,839
| Closed | -$502K | – | 4529 |
|
|
2014
Q2 | $502K | Sell |
25,839
-22,582
| -47% | -$439K | ﹤0.01% | 3128 |
|
|
2014
Q1 | $868K | Buy |
48,421
+32,085
| +196% | +$575K | ﹤0.01% | 2207 |
|
|
2013
Q4 | $173K | Sell |
16,336
-27,403
| -63% | -$290K | ﹤0.01% | 3586 |
|
|
2013
Q3 | $541K | Sell |
43,739
-29,682
| -40% | -$367K | ﹤0.01% | 2564 |
|
|
2013
Q2 | $687K | Buy |
+73,421
| New | +$687K | ﹤0.01% | 2309 |
|